Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing

被引：0
|
作者：
Jackson, Sarah A.
Roberts, Maegan
Mester, Jessica L.
Marshall, Megan L.
Postula, Kristen J. Vogel
Stettner, Amy R.
Arvai, Kevin J.
Klein, Rachel T.
Wagner, Andrew F.
Hruska, Kathleen S.
机构：
[1] GeneDx Inc, Gaithersburg, MD USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1580
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
    Filorizzo, C.
    Fanale, D.
    Incorvaia, L.
    Barraco, N.
    Bono, M.
    Brando, C.
    Calo, V.
    Cancelliere, D.
    Cucinella, A.
    Dimino, A.
    Fiorino, A.
    Magrin, L.
    Pedone, E.
    Perez, A.
    Pivetti, A.
    Sammataro, S.
    Sciacchitano, R.
    Vaccaro, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S432 - S433
  • [2] Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing
    Mester, Jessica L.
    Jackson, Sarah A.
    Postula, Kristen
    Stettner, Amy
    Solomon, Sheila
    Bissonnette, Jeffrey
    Murphy, Patricia D.
    Klein, Rachel T.
    Hruska, Kathleen S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (03): : 396 - 404
  • [3] Multi-gene panel testing for hereditary cancer risk
    Yadav, S.
    Ladkany, R.
    Fulbright, J.
    Dreyfuss, H.
    Reeves, A.
    Campian, S.
    Thomas, V.
    Zakalik, D.
    CANCER RESEARCH, 2016, 76
  • [4] Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis
    Anaclerio, Federico
    Pilenzi, Lucrezia
    Dell'Elice, Anastasia
    Ferrante, Rossella
    Grossi, Simona
    Ferlito, Luca Maria
    Marinelli, Camilla
    Gildetti, Simona
    Calabrese, Giuseppe
    Stuppia, Liborio
    Antonucci, Ivana
    FRONTIERS IN GENETICS, 2023, 14
  • [5] The clinical use of NGS multi-gene panel testing in hereditary cancer analysis
    Anaclerio, Federico
    Pilenzi, Lucrezia
    Dell'Elice, Anastasia
    Ferrante, Rossella
    Antonucci, Ivana
    Stuppia, Liborio
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 248 - 248
  • [6] Clinical management of TP53 mosaic variants found on germline genetic testing
    Ward, Abigail
    Farengo-Clark, Dana
    Mckenna, Danielle B.
    Safonov, Anton
    Good, Madeline
    Le, Anh
    Kessler, Lisa
    Shah, Payal D.
    Bradbury, Angela R.
    Domchek, Susan M.
    Nathanson, Katherine L.
    Powers, Jacquelyn
    Maxwell, Kara N.
    CANCER GENETICS, 2024, 284 : 43 - 47
  • [7] Trends in clinical introduction of multi-gene panel testing (MGPT) in hereditary cancer diagnosis
    Yoshida, Reiko
    CANCER SCIENCE, 2022, 113 : 1382 - 1382
  • [8] Prevalence of pathogenic genetic variants in patients with gastric cancer ascertained through multi-gene panel testing
    Gilad, Ophir
    Keel, Emma
    Russell, Emily M.
    Young, Sarah M. Nielsen
    Heald, Brandie
    Esplin, Ed
    Korn, W. Michael
    Roberts, Maegan
    Burke, Carol A.
    Kupfer, Sonia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] CHARACTERISTICS OF PATIENTS WITH A PRIMARY BRAIN TUMOR UNDERGOING HEREDITARY CANCER MULTI-GENE PANEL TESTING
    Azam, Sarah
    Qualmann, Krista
    Hashmi, Syed
    Ramdaney, Aarti
    Rodriguez-Buritica, David
    Dunnington, Leslie
    Jackson, Michelle
    NEURO-ONCOLOGY, 2018, 20 : 103 - 103
  • [10] Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment
    Ellisen, Leif W.
    Kurian, Allison W.
    Desmond, Andrea J.
    Mills, Meredith
    Lincoln, Stephen E.
    Shannon, Kristen M.
    Gabree, Michele
    Tung, Nadine M.
    Ford, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345